A Multi-Center, Observational Safety Registry of Subjects With Idiopathic Parkinson's Disease Previously Treated With Intraputaminal Infusion of Liatermin

CompletedOBSERVATIONAL
Enrollment

31

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

November 30, 2006

Study Completion Date

September 30, 2007

Conditions
Idiopathic Parkinson's Disease
Interventions
DRUG

Safety observation

Subjects previously enrolled in a GDNF protocol observed for 2 years after discontinuation of drug.

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Amgen

INDUSTRY

NCT00148369 - A Multi-Center, Observational Safety Registry of Subjects With Idiopathic Parkinson's Disease Previously Treated With Intraputaminal Infusion of Liatermin | Biotech Hunter | Biotech Hunter